NEPHROCLEAR
Live / Registered — Registered (as of 14 Jun 2022)
What this means for you
Registered since 14 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88563718
- Registration number
- 6760821
- Mark type
- Stylized text
- Filed
- 02 Aug 2019
- Published for opposition
- 12 Nov 2019
- Registered
- 14 Jun 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Chemical reagents and laboratory reagents for medical, medicinal pharmaceutical and veterinary use, namely, for use in the preparation of in vitro diagnostic kits; diagnostic preparations for medical, medicinal pharmaceutical and veterinary use in the field of in vitro diagnostics; immunoassay kits consisting primarily of immunological reagents for medical diagnostic use; medical diagnostic test strips for immunological analyses
- Class 010 — Medical apparatus: Medical instruments and apparatus used to detect markers for medical use in the field of in vitro diagnostics; medical and veterinary apparatus and instruments for diagnostic detection of biological molecules; Laboratory instruments and apparatus, namely, test kits comprised primarily of medical diagnostic apparatus used to detect markers, test strips, test cassettes, pipettes, test tubes, vials, and laboratory cards for diagnostic indicator purposes for immunological analysis; immunology analyzers for in vitro diagnostic use
Owner
- BIOM�RIEUX, INC., SALT LAKE CITY, UT, US
- Astute Medical, Inc., San Diego, CA, US
- Astute Medical, Inc., San Diego, CA, US
- Astute Medical, Inc., San Diego, CA, US
Prosecution history
- 11 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Apr 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Apr 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Mar 2022 — NON-FINAL ACTION E-MAILED
- 30 Mar 2022 — SU - NON-FINAL ACTION - WRITTEN
- 24 Feb 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Feb 2022 — USE AMENDMENT FILED
- 24 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Feb 2022 — TEAS STATEMENT OF USE RECEIVED